{"id":"https://openalex.org/A5117091040","orcid":"https://orcid.org/0000-0003-1254-1042","observed_orcids":["https://orcid.org/0000-0003-1254-1042"],"display_name":"Byron R. Inapanta","raw_author_names":["Byron R. Inapanta","Byron Raul Inapanta"],"full_name":"Byron R. Inapanta","works_count":2,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.5,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117091040","orcid":"https://orcid.org/0000-0003-1254-1042","observed_orcids":["https://orcid.org/0000-0003-1254-1042"]},"affiliations":[{"institution":{"id":"https://openalex.org/I3130401523","ror":"https://ror.org/04jjswc10","display_name":"Universidad Yachay Tech","country_code":"EC","type":"education","lineage":["https://openalex.org/I3130401523"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I3130401523","ror":"https://ror.org/04jjswc10","display_name":"Universidad Yachay Tech","country_code":"EC","type":"education","lineage":["https://openalex.org/I3130401523"]}],"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10133","display_name":"News Media Framing and Political Communication","count":1,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13625","display_name":"Journalism and Media Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T13979","display_name":"Communication and COVID-19 Impact","value":1.14e-05,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","value":2.5e-06,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10133","display_name":"News Media Framing and Political Communication","value":1.6e-06,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","score":0.6068000197410583},{"id":"114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","score":0.5878999829292297},{"id":"144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","score":0.4512346386909485},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.3319999873638153},{"id":"13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","score":0.2969000041484833}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":1}],"display_name_alternatives":["Byron R. Inapanta","Byron Raul Inapanta"],"block_key":"b inapanta","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117091040","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5117091040","updated_date":"2026-11-10T14:30:39","created_date":"2025-04-10T00:00:00"}